The position of combined medical treatment in acromegaly
Arch. endocrinol. metab. (Online)
;
63(6): 646-652, Nov.-Dec. 2019.
Artículo
en Inglés
| LILACS
| ID: biblio-1055016
ABSTRACT
ABSTRACT Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect both additive and synergistic effects. This review focuses on combination medical treatment and its current position in acromegaly, based on clinical studies evaluating the efficacy and safety of combined medical treatment(s) and our own experiences with combination therapy. Arch Endocrinol Metab. 2019;63(6)646-52
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Somatostatina
/
Receptores de Somatostatina
/
Agonistas de Dopamina
/
Hormona de Crecimiento Humana
Límite:
Humanos
Idioma:
Inglés
Revista:
Arch. endocrinol. metab. (Online)
Asunto de la revista:
Endocrinologia
/
Metabolismo
Año:
2019
Tipo del documento:
Artículo
País de afiliación:
Hungria
Institución/País de afiliación:
Erasmus University Medical Center Rotterdam/hungria
Similares
MEDLINE
...
LILACS
LIS